Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
    Contact Us
  • Affiliated Brands
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    Visit JONS
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
    Visit TON
  • Healthcare Providers
  • Contribute

All Articles

Growing Role of Biomarkers in the Treatment of Patients with Acute Myeloid Leukemia
Growing Role of Biomarkers in the Treatment of Patients with Acute Myeloid Leukemia
By Meg Barbor, MPH
Biomarkers, Leukemia
May 2018 – Cancer Biomarkers and Molecular Testing
In recent years, new treatments for acute myeloid leukemia have improved outcomes. In 2017, 2 new drugs were approved for patients with this type of blood cancer linked to a specific biomarker. Read More ›
Understanding dMMR and MSI-H Tumor Biomarkers
Understanding dMMR and MSI-H Tumor Biomarkers
By Sophie Granger
Biomarkers
May 2018 – Cancer Biomarkers and Molecular Testing
The understanding of the role of dMMR or MSI-H biomarkers in cancer has led to the first approval of a cancer drug based on a biomarker instead of a specific tumor type. Read More ›
What Are Cancer Biomarkers, and Why Are They Important?
What Are Cancer Biomarkers, and Why Are They Important?
By Kristen Chanley
Biomarkers, Genetics and Genomics
May 2018 – Cancer Biomarkers and Molecular Testing
Biomarkers are biologic markers that indicate changes in our genes and may increase the risk of cancer. Read More ›
My Biomarker Story, and Why I Advocate for Genetic Testing
My Biomarker Story, and Why I Advocate for Genetic Testing
By Wenora Y. Johnson
Patient Advocacy, Biomarkers, Colorectal Cancer, Essays
May 2018 – Cancer Biomarkers and Molecular Testing
Wenora Y. Johnson, 3-time survivor, shares her cancer story and encourages patients to ask their care team about biomarker testing. Read More ›
FDA Approves First Direct-to-Consumer Genetic Test for 3 Types of BRCA Mutations in Men and Women
FDA Approves First Direct-to-Consumer Genetic Test for 3 Types of BRCA Mutations in Men and Women
By Dana Taylor
FDA Approvals, News & Updates, Genetics and Genomics
May 2018 – Cancer Biomarkers and Molecular Testing
This first-ever direct-to-consumer genetic test can provide information on potential risks to individuals who may not have access to genetic screening, but the information may be misleading without feedback from experts. Read More ›
Quizartinib Significantly Improves Survival Over Chemotherapy in Patients with Relapsed/Refractory AML and FLT3-ITD Mutation
Quizartinib Significantly Improves Survival Over Chemotherapy in Patients with Relapsed/Refractory AML and FLT3-ITD Mutation
Leukemia, Web Exclusives
Web Exclusives
This is the first treatment that targets patients with AML and the FLT3-ITD mutation. In this clinical trial, patients who received quizartinib lived longer without disease progression than those receiving chemotherapy. Read More ›
Skin Cancer Awareness Month
Skin Cancer Awareness Month
Skin Cancer, Slideshows, Web Exclusives
Web Exclusives
May is Skin Cancer Awareness Month! View this slideshow to learn the latest statistics in the United States, leading causes and preventive measures, and quick facts on melanoma, one of the most common types of skin cancer. Conquer cancer with knowledge. Read More ›
Let There Be Spring!
Let There Be Spring!
By Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
A Note From Your Navigator
April 2018 Vol 4 No 2
Happy spring 2018! Though the weather may not feel like spring, the calendar says it is. Let me give you a quick snapshot of what this issue of CONQUER contains. Read More ›
Lessons in Love and Resurrection: My Journey Through Leukemia
Lessons in Love and Resurrection: My Journey Through Leukemia
By Shaun Willson
Leukemia, Essays
April 2018 Vol 4 No 2
Shaun Willson’s story is one of daring independence and strength, as he championed through an acute myeloid leukemia diagnosis while also being the primary caregiver to his wife, Deborah, during her battle with metastatic cancer. Read More ›
Working with Your Navigator
Working with Your Navigator
By Sharon S. Gentry, MSN, RN, HON-ONN-CG, AOCN, CBCN
From Your Navigator
April 2018 Vol 4 No 2
Nurse Navigator Sharon Gentry explains the critical role a “navigator” plays throughout cancer treatment and offers useful strategies for patients to communicate with and properly utilize their navigators to receive the best possible care. Read More ›

Page 120 of 165